Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma

Successful dual antiviral therapy with remdesivir and ensitrelvir in a case of prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma

Prolonged COVID-19 following B-cell depleting immunotherapy for malignant lymphoma is characterized by repeated cycles of remission followed by symptom recurrence, persistent detection of SARS-CoV-2, and profound humoral immunodeficiency. To the best of our knowledge, the present report is the first...

Full description

Bibliographic Details
Main Authors: Seowoong Jung, Yu Yagi, Kazuaki Fukushima, Yukari Nishikawa, Masaru Tanaka, Taiichiro Kobayashi, Keishiro Yajima, Atsushi Ajisawa, Akifumi Imamura
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:IDCases
Subjects:
Prolonged COVID-19
B-cell depleting immunotherapy
Remdesivir
Ensitrelvir
Dual antiviral therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250923002147

Internet

http://www.sciencedirect.com/science/article/pii/S2214250923002147

Similar Items